Defunct Company
Total Trials
36
As Lead Sponsor
27
As Collaborator
9
Total Enrollment
21,668
NCT00866593
A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression
Phase: Phase 2/3
Role: Collaborator
Start: Mar 31, 2009
Completion: Mar 31, 2010
NCT00933452
A Study to Evaluate the Pharmacokinetics of Duloxetine in Chinese Han Healthy Subjects
Phase: Phase 1
Start: Jul 31, 2009
Completion: Dec 31, 2009
NCT01175915
A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
Phase: N/A
Role: Lead Sponsor
Start: May 31, 2010
Completion: Aug 31, 2010
NCT02117401
A Prospective, Multi-center, Randomized Controlled Study of Muscle Relaxation Effect and Safety of Mivacurium Chloride in Pediatric Surgery Patients
Phase: Phase 4
Start: Jan 31, 2012
Completion: Jun 30, 2013
NCT01588236
Effect of KYG0395 on Primary Dysmenorrhea
Phase: Phase 2
Start: May 31, 2012
Completion: Jul 31, 2015
NCT01729897
Etomidate Emulsion for Sedation in Patients Scheduled for Upper Gastrointestinal (GI) Endoscopy
Completion: Oct 31, 2012
NCT01958957
A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.
Start: Jun 30, 2013
Completion: Oct 31, 2014
NCT01913054
Combined Use of Etomidate and Propofol in Painless Gastroscopy.
Start: Aug 31, 2013
Completion: Dec 31, 2013
NCT02031523
Multi-center Clinical Trials of Sanjie Analgesic Capsule in Treating Endometriosis
Start: Oct 31, 2013
Completion: Dec 31, 2015
NCT02046031
Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.
Start: Feb 28, 2014
Completion: Jun 30, 2014
NCT02035111
A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.
Start: Mar 31, 2014
Completion: Nov 30, 2015
NCT02264535
A Pilot Study for Ginkgolides Meglumine Injection Skin Testing.
Start: Jun 30, 2014
Completion: Not specified
NCT02233972
A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam
Start: Aug 31, 2014
NCT02473601
Mivacurium Chloramine Muscle Relaxation Effect in Patients With Liver Cirrhosis
Start: Oct 31, 2014
Completion: Sep 30, 2015
NCT03219645
Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic Stroke
Start: Jul 15, 2017
Completion: Dec 31, 2017
NCT03931668
Tolerance, PK and PD Effects Study of TPN-672 in Chinese Healthy Volunteers
Phase: Early Phase 1
Start: Apr 17, 2019
Completion: Dec 17, 2020
NCT04839926
A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects
Start: Mar 2, 2021
Completion: Aug 1, 2021
NCT05015192
Single Ascending Dose Study of NH102 in Healthy Subjects
Start: Aug 12, 2021
Completion: Jan 11, 2022
NCT07200362
Study of Compound Nanxing Zhitong Ointment in the Treatment of Chronic Pain in Musculoskeletal System
Start: Oct 30, 2021
Completion: Feb 28, 2024
NCT05559645
Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)
Start: Nov 18, 2021
Completion: Jun 30, 2026
NCT05176873
A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics of DZD8586 in Healthy Adult Participants
Start: Dec 9, 2021
Completion: May 22, 2022
NCT05201365
A Prospective Cohort Study of Compound Nanxing Zhitong Ointment
Start: Jan 31, 2022
Completion: Jan 31, 2024
NCT05192304
Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TPN672 Tablets Maleate in Patients With Schizophrenia
Start: Feb 1, 2022
Completion: Mar 1, 2024
NCT06278389
Single Ascending Dose, Food Effects and Drug-Drug Interactions of ACC017 Tablets in Healthy Adult Participants
Start: Jan 24, 2024
Completion: Apr 23, 2024
NCT06424613
Effects of Lithium on Suicide Prevention in Adolescents and Young Adults With Bipolar Disorder in China
Start: Apr 18, 2024
Completion: Dec 31, 2024
NCT06719310
Phase Ib/IIa Clinical Study of ACC017 Tablets
Phase: Phase 1/2
Start: Aug 28, 2024
Completion: Nov 30, 2025
NCT06679998
A Phase I Clinical Trial Evaluating the Safety, Tolerability and Pharmacokinetics of AAPB for Injection
Start: Nov 14, 2024
Completion: Mar 26, 2026
NCT06842992
A Phase II Study to Evaluate NH102 for Depression
Start: Dec 4, 2024
Completion: Mar 10, 2026
NCT06864624
Perioperative Treatment of Sunvozertinib in Stage II-IIIB NSCLC
Start: Feb 18, 2025
Completion: Jun 30, 2029
NCT06870058
A Study of NH280105 in Healthy Adult Participants
Start: Mar 12, 2025
Completion: Feb 1, 2026
NCT07110103
Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC
Start: Aug 15, 2025
Completion: Jun 30, 2028
NCT07126171
A Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya Fever
Start: Aug 28, 2025
Completion: Feb 18, 2026
NCT07079475
Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8)
Start: Aug 31, 2025
Completion: Dec 31, 2029
NCT07139873
A Study of DZD8586 Versus Investigator's Choice in r/r CLL/SLL (TAI-SHAN6)
Phase: Phase 3
Start: Sep 30, 2025
NCT07154264
A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)
Start: Oct 31, 2025
Completion: Jan 31, 2030
NCT07182682
A Phase 3 Study of Sunvozertinib Versus Placebo as Adjuvant Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations or PACC Mutations After Radical Surgery
Completion: Jan 31, 2031